Mutual Funds

Invesco Health Care Fund

Equity | Sector Equity

Objective & Strategy

The fund seeks long-term growth of capital by investing in equity securities of health care companies throughout the world.

as of 02/28/2019

Morningstar Rating

Overall Rating - Health Category

As of 02/28/2019 the Fund had an overall rating of 2 stars out of 132 funds and was rated 2 stars out of 132 funds, 2 stars out of 121 funds and 2 stars out of 98 funds for the 3-, 5- and 10- year periods, respectively.

Morningstar details

Source: Morningstar Inc. Ratings are based on a risk-adjusted return measure that accounts for variation in a fund's monthly performance, placing more emphasis on downward variations and rewarding consistent performance. Open-end mutual funds and exchange-traded funds are considered a single population for comparison purposes. Ratings are calculated for funds with at least a three year history. The overall rating is derived from a weighted average of three-, five- and 10-year rating metrics, as applicable, excluding sales charges and including fees and expenses. ©2019 Morningstar Inc. All rights reserved. The information contained herein is proprietary to Morningstar and/or its content providers. It may not be copied or distributed and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not guarantee future results. The top 10% of funds in a category receive five stars, the next 22.5% four stars, the next 35% three stars, the next 22.5% two stars and the bottom 10% one star. Ratings are subject to change monthly. Had fees not been waived and/or expenses reimbursed currently or in the past, the Morningstar rating would have been lower. Ratings for other share classes may differ due to different performance characteristics.

Management team

as of 02/28/2019

Top Equity Holdings | View all

% of Total Assets
Novartis ADR 4.57
UnitedHealth 4.37
Johnson & Johnson 4.18
Thermo Fisher Scientific 4.03
Medtronic 3.85
AstraZeneca 3.62
Merck 3.32
Zimmer 2.96
Eli Lilly 2.87
Abbott Laboratories 2.52

May not equal 100% due to rounding.

Holdings are subject to change and are not buy/sell recommendations.

as of 02/28/2019 12/31/2018

Average Annual Returns (%)

  Incept.
Date
Max
Load (%)
Since
Incept. (%)
YTD (%) 1Y (%) 3Y (%) 5Y (%) 10Y (%)
NAV 07/15/2005 N/A 8.40 11.08 13.25 10.44 5.34 14.05
Load 07/15/2005 N/A N/A N/A N/A N/A N/A N/A
Performance quoted is past performance and cannot guarantee comparable future results; current performance may be lower or higher. Investment return and principal value will vary so that you may have a gain or a loss when you sell shares.

The Investor Class shares have no sales charge; therefore, performance is at NAV. Investor Class shares are closed to most investors. Please see the prospectus for more details.

Performance figures reflect reinvested distributions and changes in net asset value (NAV) and the effect of the maximum sales charge unless otherwise stated.

Effective April 30, 2018, Invesco Global Health Care Fund was renamed Invesco Health Care Fund.

as of 02/28/2019 12/31/2018

Annualized Benchmark Returns


Index Name 1 Mo (%) 3 Mo (%) 1Y (%) 3Y (%) 5Y (%) 10Y (%)
MSCI Wld Hlth Cr ND IX 1.97 -1.43 8.97 10.49 7.49 14.54
MSCI World IX ND 3.01 2.58 0.43 12.64 6.53 13.05
MSCI Wld Hlth Cr ND IX -8.07 -9.43 2.51 4.60 7.58 11.89
MSCI World IX ND -7.60 -13.42 -8.71 6.30 4.56 9.67

Source: FactSet Research Systems Inc.

Source: FactSet Research Systems Inc.

An investment cannot be made directly in an index.

Expense Ratio per Prospectus

Management Fee 0.63
12b-1 Fee 0.25
Other Expenses 0.21
Interest/Dividend Exp 0.00
Total Other Expenses 0.21
Acquired Fund Fees and Expenses (Underlying Fund Fees & Expenses) 0.01
Total Annual Fund Operating Expenses 1.10
Contractual Waivers/Reimbursements N/A
Net Expenses - PER PROSPECTUS 1.10
Additional Waivers/Reimbursements 0.00
Net Expenses - With Additional Fee Reduction 1.10
This information is updated per the most recent prospectus.

Historical Prices

From   to
No history records found for this date range

Distributions

From   to
    Capital Gains Reinvestment
Price ($)
Ex-Date Income Short Term Long Term
12/14/2018 N/A 0.1126 2.7898 34.34
12/13/2017 N/A N/A 2.4481 35.55
12/13/2016 0.0749 N/A 0.7374 33.15
12/11/2015 N/A 0.3516 5.4036 36.85
12/12/2014 N/A 0.0070 4.9235 42.60
12/13/2013 0.0126 0.2353 3.2195 38.13
09/19/2013 0.0508 N/A N/A 40.01
12/07/2012 0.1229 N/A 2.2410 30.42
12/09/2011 0.1436 N/A 0.4830 26.77
12/12/2008 N/A N/A 0.6010 18.95
12/14/2007 N/A 0.7152 2.1662 28.90
12/15/2006 N/A N/A 3.0024 28.638
12/16/2005 N/A N/A 0.9343 30.288
as of 02/28/2019

Sector Breakdown

May not equal 100% due to rounding.

The holdings are organized according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of Morgan Stanley Capital International Inc. and Standard & Poor's.

as of 02/28/2019

Fund Characteristics

3-Year Alpha -0.68%
3-Year Beta 1.10
3-Year R-Squared 0.84
3-Year Sharpe Ratio 0.65
3-Year Standard Deviation 14.37
Number of Securities 69
Total Assets $1,375,660,783.00
Wghtd Med Mkt Cap MM$ $66,448.00

Source: FactSet Research Systems Inc., StyleADVISOR

Benchmark:  MSCI Wld Hlth Cr ND IX

as of 02/28/2019

Top Equity Holdings | View all

% of Total Assets
Novartis ADR 4.57
UnitedHealth 4.37
Johnson & Johnson 4.18
Thermo Fisher Scientific 4.03
Medtronic 3.85
AstraZeneca 3.62
Merck 3.32
Zimmer 2.96
Eli Lilly 2.87
Abbott Laboratories 2.52

May not equal 100% due to rounding.

Holdings are subject to change and are not buy/sell recommendations.

as of 02/28/2019

Top Industries

  % of Total Assets
Pharmaceuticals 32.08
Biotechnology 19.52
Health Care Equipment 17.37
Managed Health Care 12.43
Life Sciences Tools & Services 7.58
Health Care Services 2.58
Health Care Facilities 1.66
Health Care Technology 1.32
Health Care Supplies 0.85
Drug Retail 0.42

May not equal 100% due to rounding.

The holdings are organized according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of Morgan Stanley Capital International Inc. and Standard & Poor's.

as of 02/28/2019

Top Countries

  % of Total Assets
United States 75.36
Switzerland 6.31
United Kingdom 3.62
France 2.72
Denmark 2.17
Brazil 1.73
Netherlands 1.59
Japan 0.92
Luxembourg 0.80
Ireland 0.60

May not equal 100% due to rounding.

as of 03/19/2019

GTHIX

NAV Change ($)
$37.40 0.20
N/As may appear until data is available. Data is usually updated between 3 and 6 p.m. CST.

Fund Details

  • Distribution Frequency Annually
  • NASDAQ GTHIX
  • WSJ Abrev. N/A
  • CUSIP 00141T171
  • Fund Type Equity
  • Geography Type Global
  • Inception Date 07/15/2005
  • Fiscal Year End 10/31
  • Min Initial Investment N/A
  • Subsequent Investment N/A
  • Min Initial IRA Investment N/A
  • Fund Number 0251
  • Tax ID 93-1006889